Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

BACKGROUND: Kidneys from deceased donors are being used to meet the growing need for grafts. However, delayed graft function (DGF) and acute rejection incidences are high, leading to adverse effects on graft outcomes. Optimal induction intervention should include both renal structure injury repair a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qipeng, Huang, Zhengyu, Han, Fei, Zhao, Ming, Cao, Ronghua, Zhao, Daqiang, Hong, Liangqing, Na, Ning, Li, Heng, Miao, Bin, Hu, Jianmin, Meng, Fanhang, Peng, Yanwen, Sun, Qiquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842532/
https://www.ncbi.nlm.nih.gov/pubmed/29514693
http://dx.doi.org/10.1186/s12967-018-1422-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842532/
https://www.ncbi.nlm.nih.gov/pubmed/29514693
http://dx.doi.org/10.1186/s12967-018-1422-x

Ejemplares similares